Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. [electronic resource]
Producer: 20181211Description: 10701-10714 p. digitalISSN:- 2040-3372
- Antineoplastic Agents -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Drug Carriers
- Female
- Humans
- Ibuprofen -- administration & dosage
- Lipids
- Male
- Nanoparticles
- Naproxen -- administration & dosage
- Organometallic Compounds -- administration & dosage
- Polymers
- Prostatic Neoplasms -- drug therapy
- Ruthenium
- Tissue Distribution
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.